{
    "info": {
        "nct_id": "NCT02950259",
        "official_title": "A Phase Ib Study to Assess the Safety, Tolerability and Immunologic Activity of Preoperative IRX 2 In Early Stage Breast Cancer",
        "inclusion_criteria": "* Invasive breast cancer of any receptor subtype diagnosed by core-needle biopsy\n* To undergo surgical resection with curative intent by partial mastectomy (lumpectomy) or mastectomy or\n* Triple negative breast cancer (defined by ER<10%, PR<10%, and HER2-negative by NCCN guidelines), T1c+ tumors for which neoadjuvant anthracycline-based and non-platinum containing chemotherapy is planned\n* Tumor >5 mm in maximum diameter by ultrasound or mammography. (Subjects with smaller tumors may be included at the discretion of the Principal Investigator.)\n* Willing and able to provide written informed consent, including consent for use of available tissue and required blood draws for research purposes\n* Availability of at least one tumor-bearing core specimen from the breast cancer diagnostic biopsy\n* Karnofsky Performance status (KPS) 70% or greater.\n* Female or male â‰¥18 years of age on day of signing informed consent.\n* Adequate organ function as defined by protocol specified lab results\nHealthy volunteers allowed",
        "exclusion_criteria": "* Prior neoadjuvant systemic therapy is planned\n* Prior surgery, radiotherapy or chemotherapy for this cancer (other than core-needle biopsy)\n* Received an investigational agent within 4 weeks of the first dose of treatment.\n* Diagnosis of immunodeficiency or has received more than replacement doses of corticosteroids any other immunosuppressive therapy within 4 weeks of the first dose of treatment\n* Hypersensitivity to IRX 2, cyclophosphamide, indomethacin, aspirin or ciprofloxacin.\n* Chronic anticoagulation, not including aspirin, but including heparins, warfarin, oral anticoagulants or other platelet function inhibitors, that cannot, in the documented opinion of the investigator, safely be interrupted from at least 2 days prior to the initiation of the study regimen until after surgical resection of the tumor.\n* Another malignancy that required active treatment within 6 months of the first dose of treatment\n* History or current evidence of any condition, therapy, or laboratory abnormality that might confound the results of the trial, interfere with the subject's participation for the full duration of the trial, such that trial participation is not in the best interest of the subject, including but not limited to uncontrolled hypertension or clinically significant cardiovascular disease, myocardial infarction within the previous 3 months, active infection or pneumonitis or other pulmonary disease requiring systemic therapy, clinically significant gastritis or peptic ulcer disease (that would preclude the use of indomethacin), stroke of other symptoms of cerebral vascular insufficient within the last 3 months, autoimmune disease that has required systemic treatment within the past 2 years (other than hormone replacement doses), or uncontrolled psychiatric or substance abuse disorders.\n* Pregnancy or lactation.\n* Known history of Human Immunodeficiency Virus (HIV) (HIV 1/2 antibodies), active Hepatitis B (e.g., HBsAg reactive) or Hepatitis C (e.g., HCV RNA [qualitative] is detected).",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "identified_line": {
                "line": "* Willing and able to provide written informed consent, including consent for use of available tissue and required blood draws for research purposes",
                "criterions": [
                    {
                        "exact_snippets": "Willing and able to provide written informed consent",
                        "criterion": "written informed consent",
                        "requirement": {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Willing and able to provide written informed consent",
                        "criterion": "written informed consent",
                        "requirement": {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "consent for use of available tissue",
                        "criterion": "consent for use of available tissue",
                        "requirement": {
                            "requirement_type": "consent",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "consent for ... required blood draws for research purposes",
                        "criterion": "consent for required blood draws for research purposes",
                        "requirement": {
                            "requirement_type": "consent",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Willing and able to provide written informed consent",
                        "criterion": "written informed consent",
                        "requirement": {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Willing and able to provide written informed consent",
                        "criterion": "written informed consent",
                        "requirement": {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "consent for use of available tissue",
                        "criterion": "consent for use of available tissue",
                        "requirement": {
                            "requirement_type": "consent",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "consent for ... required blood draws for research purposes",
                        "criterion": "consent for required blood draws for research purposes",
                        "requirement": {
                            "requirement_type": "consent",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Karnofsky Performance status (KPS) 70% or greater.",
                "criterions": [
                    {
                        "exact_snippets": "Karnofsky Performance status (KPS) 70% or greater",
                        "criterion": "Karnofsky Performance status (KPS)",
                        "requirement": {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": ">=",
                                "value": 70,
                                "unit": "%"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Karnofsky Performance status (KPS) 70% or greater",
                        "criterion": "Karnofsky Performance status (KPS)",
                        "requirement": {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": ">=",
                                "value": 70,
                                "unit": "%"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "Healthy volunteers allowed",
                "criterions": [
                    {
                        "exact_snippets": "Healthy volunteers allowed",
                        "criterion": "healthy volunteer status",
                        "requirement": {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Healthy volunteers allowed",
                        "criterion": "healthy volunteer status",
                        "requirement": {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Availability of at least one tumor-bearing core specimen from the breast cancer diagnostic biopsy",
                "criterions": [
                    {
                        "exact_snippets": "Availability of at least one tumor-bearing core specimen from the breast cancer diagnostic biopsy",
                        "criterion": "tumor-bearing core specimen from breast cancer diagnostic biopsy",
                        "requirement": {
                            "requirement_type": "availability",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Availability of at least one tumor-bearing core specimen from the breast cancer diagnostic biopsy",
                        "criterion": "tumor-bearing core specimen from breast cancer diagnostic biopsy",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "specimen"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Availability of at least one tumor-bearing core specimen from the breast cancer diagnostic biopsy",
                        "criterion": "tumor-bearing core specimen from breast cancer diagnostic biopsy",
                        "requirement": {
                            "requirement_type": "availability",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Availability of at least one tumor-bearing core specimen from the breast cancer diagnostic biopsy",
                        "criterion": "tumor-bearing core specimen from breast cancer diagnostic biopsy",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "specimen"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Invasive breast cancer of any receptor subtype diagnosed by core-needle biopsy",
                "criterions": [
                    {
                        "exact_snippets": "Invasive breast cancer",
                        "criterion": "breast cancer",
                        "requirement": {
                            "requirement_type": "invasiveness",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "any receptor subtype",
                        "criterion": "receptor subtype of breast cancer",
                        "requirement": {
                            "requirement_type": "subtype",
                            "expected_value": "any"
                        }
                    },
                    {
                        "exact_snippets": "diagnosed by core-needle biopsy",
                        "criterion": "diagnosis method",
                        "requirement": {
                            "requirement_type": "method",
                            "expected_value": "core-needle biopsy"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Invasive breast cancer",
                        "criterion": "breast cancer",
                        "requirement": {
                            "requirement_type": "invasiveness",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "any receptor subtype",
                        "criterion": "receptor subtype of breast cancer",
                        "requirement": {
                            "requirement_type": "subtype",
                            "expected_value": "any"
                        }
                    },
                    {
                        "exact_snippets": "diagnosed by core-needle biopsy",
                        "criterion": "diagnosis method",
                        "requirement": {
                            "requirement_type": "method",
                            "expected_value": "core-needle biopsy"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Adequate organ function as defined by protocol specified lab results",
                "criterions": [
                    {
                        "exact_snippets": "Adequate organ function as defined by protocol specified lab results",
                        "criterion": "organ function",
                        "requirement": {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Adequate organ function as defined by protocol specified lab results",
                        "criterion": "organ function",
                        "requirement": {
                            "requirement_type": "definition source",
                            "expected_value": "protocol specified lab results"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Adequate organ function as defined by protocol specified lab results",
                        "criterion": "organ function",
                        "requirement": {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Adequate organ function as defined by protocol specified lab results",
                        "criterion": "organ function",
                        "requirement": {
                            "requirement_type": "definition source",
                            "expected_value": "protocol specified lab results"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Triple negative breast cancer (defined by ER<10%, PR<10%, and HER2-negative by NCCN guidelines), T1c+ tumors for which neoadjuvant anthracycline-based and non-platinum containing chemotherapy is planned",
                "criterions": [
                    {
                        "exact_snippets": "Triple negative breast cancer (defined by ER<10%, PR<10%, and HER2-negative by NCCN guidelines)",
                        "criterion": "breast cancer subtype",
                        "requirement": {
                            "requirement_type": "subtype",
                            "expected_value": "triple negative"
                        }
                    },
                    {
                        "exact_snippets": "Triple negative breast cancer (defined by ER<10%, PR<10%, and HER2-negative by NCCN guidelines)",
                        "criterion": "breast cancer subtype",
                        "requirement": {
                            "requirement_type": "ER expression",
                            "expected_value": {
                                "operator": "<",
                                "value": 10,
                                "unit": "%"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Triple negative breast cancer (defined by ER<10%, PR<10%, and HER2-negative by NCCN guidelines)",
                        "criterion": "breast cancer subtype",
                        "requirement": {
                            "requirement_type": "PR expression",
                            "expected_value": {
                                "operator": "<",
                                "value": 10,
                                "unit": "%"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Triple negative breast cancer (defined by ER<10%, PR<10%, and HER2-negative by NCCN guidelines)",
                        "criterion": "breast cancer subtype",
                        "requirement": {
                            "requirement_type": "HER2 status",
                            "expected_value": "negative"
                        }
                    },
                    {
                        "exact_snippets": "T1c+ tumors",
                        "criterion": "tumor stage",
                        "requirement": {
                            "requirement_type": "stage",
                            "expected_value": "T1c or higher"
                        }
                    },
                    {
                        "exact_snippets": "for which neoadjuvant anthracycline-based and non-platinum containing chemotherapy is planned",
                        "criterion": "planned chemotherapy regimen",
                        "requirement": {
                            "requirement_type": "neoadjuvant anthracycline-based chemotherapy",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "for which neoadjuvant anthracycline-based and non-platinum containing chemotherapy is planned",
                        "criterion": "planned chemotherapy regimen",
                        "requirement": {
                            "requirement_type": "non-platinum containing chemotherapy",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Triple negative breast cancer (defined by ER<10%, PR<10%, and HER2-negative by NCCN guidelines)",
                                "criterion": "breast cancer subtype",
                                "requirement": {
                                    "requirement_type": "subtype",
                                    "expected_value": "triple negative"
                                }
                            },
                            {
                                "exact_snippets": "Triple negative breast cancer (defined by ER<10%, PR<10%, and HER2-negative by NCCN guidelines)",
                                "criterion": "breast cancer subtype",
                                "requirement": {
                                    "requirement_type": "ER expression",
                                    "expected_value": {
                                        "operator": "<",
                                        "value": 10,
                                        "unit": "%"
                                    }
                                }
                            },
                            {
                                "exact_snippets": "Triple negative breast cancer (defined by ER<10%, PR<10%, and HER2-negative by NCCN guidelines)",
                                "criterion": "breast cancer subtype",
                                "requirement": {
                                    "requirement_type": "PR expression",
                                    "expected_value": {
                                        "operator": "<",
                                        "value": 10,
                                        "unit": "%"
                                    }
                                }
                            },
                            {
                                "exact_snippets": "Triple negative breast cancer (defined by ER<10%, PR<10%, and HER2-negative by NCCN guidelines)",
                                "criterion": "breast cancer subtype",
                                "requirement": {
                                    "requirement_type": "HER2 status",
                                    "expected_value": "negative"
                                }
                            }
                        ]
                    },
                    {
                        "exact_snippets": "T1c+ tumors",
                        "criterion": "tumor stage",
                        "requirement": {
                            "requirement_type": "stage",
                            "expected_value": "T1c or higher"
                        }
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "for which neoadjuvant anthracycline-based and non-platinum containing chemotherapy is planned",
                                "criterion": "planned chemotherapy regimen",
                                "requirement": {
                                    "requirement_type": "neoadjuvant anthracycline-based chemotherapy",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "for which neoadjuvant anthracycline-based and non-platinum containing chemotherapy is planned",
                                "criterion": "planned chemotherapy regimen",
                                "requirement": {
                                    "requirement_type": "non-platinum containing chemotherapy",
                                    "expected_value": true
                                }
                            }
                        ]
                    }
                ]
            }
        }
    ],
    "exclusion_lines": [
        {
            "identified_line": {
                "line": "* Prior surgery, radiotherapy or chemotherapy for this cancer (other than core-needle biopsy)",
                "criterions": [
                    {
                        "exact_snippets": "Prior surgery ... for this cancer (other than core-needle biopsy)",
                        "criterion": "prior surgery for this cancer",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Prior surgery ... for this cancer (other than core-needle biopsy)",
                        "criterion": "prior surgery for this cancer",
                        "requirement": {
                            "requirement_type": "exception",
                            "expected_value": "core-needle biopsy"
                        }
                    },
                    {
                        "exact_snippets": "Prior ... radiotherapy ... for this cancer",
                        "criterion": "prior radiotherapy for this cancer",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Prior ... chemotherapy for this cancer",
                        "criterion": "prior chemotherapy for this cancer",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Prior surgery ... for this cancer (other than core-needle biopsy)",
                                "criterion": "prior surgery for this cancer",
                                "requirement": {
                                    "requirement_type": "history",
                                    "expected_value": true
                                }
                            },
                            {
                                "not_criteria": {
                                    "exact_snippets": "Prior surgery ... for this cancer (other than core-needle biopsy)",
                                    "criterion": "prior surgery for this cancer",
                                    "requirement": {
                                        "requirement_type": "exception",
                                        "expected_value": "core-needle biopsy"
                                    }
                                }
                            }
                        ]
                    },
                    {
                        "exact_snippets": "Prior ... radiotherapy ... for this cancer",
                        "criterion": "prior radiotherapy for this cancer",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Prior ... chemotherapy for this cancer",
                        "criterion": "prior chemotherapy for this cancer",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Hypersensitivity to IRX 2, cyclophosphamide, indomethacin, aspirin or ciprofloxacin.",
                "criterions": [
                    {
                        "exact_snippets": "Hypersensitivity to IRX 2",
                        "criterion": "hypersensitivity to IRX 2",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Hypersensitivity to ... cyclophosphamide",
                        "criterion": "hypersensitivity to cyclophosphamide",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Hypersensitivity to ... indomethacin",
                        "criterion": "hypersensitivity to indomethacin",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Hypersensitivity to ... aspirin",
                        "criterion": "hypersensitivity to aspirin",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Hypersensitivity to ... ciprofloxacin",
                        "criterion": "hypersensitivity to ciprofloxacin",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Hypersensitivity to IRX 2",
                        "criterion": "hypersensitivity to IRX 2",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Hypersensitivity to ... cyclophosphamide",
                        "criterion": "hypersensitivity to cyclophosphamide",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Hypersensitivity to ... indomethacin",
                        "criterion": "hypersensitivity to indomethacin",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Hypersensitivity to ... aspirin",
                        "criterion": "hypersensitivity to aspirin",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Hypersensitivity to ... ciprofloxacin",
                        "criterion": "hypersensitivity to ciprofloxacin",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Another malignancy that required active treatment within 6 months of the first dose of treatment",
                "criterions": [
                    {
                        "exact_snippets": "Another malignancy that required active treatment within 6 months of the first dose of treatment",
                        "criterion": "another malignancy",
                        "requirement": {
                            "requirement_type": "active treatment within 6 months of the first dose of treatment",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Another malignancy that required active treatment within 6 months of the first dose of treatment",
                        "criterion": "another malignancy",
                        "requirement": {
                            "requirement_type": "active treatment within 6 months of the first dose of treatment",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Diagnosis of immunodeficiency or has received more than replacement doses of corticosteroids any other immunosuppressive therapy within 4 weeks of the first dose of treatment",
                "criterions": [
                    {
                        "exact_snippets": "Diagnosis of immunodeficiency",
                        "criterion": "immunodeficiency",
                        "requirement": {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "has received more than replacement doses of corticosteroids ... within 4 weeks of the first dose of treatment",
                        "criterion": "corticosteroid therapy",
                        "requirement": {
                            "requirement_type": "dose",
                            "expected_value": {
                                "operator": ">",
                                "value": 1,
                                "unit": "replacement dose"
                            }
                        }
                    },
                    {
                        "exact_snippets": "has received more than replacement doses of corticosteroids ... within 4 weeks of the first dose of treatment",
                        "criterion": "corticosteroid therapy",
                        "requirement": {
                            "requirement_type": "time_window",
                            "expected_value": {
                                "operator": "<=",
                                "value": 4,
                                "unit": "weeks"
                            }
                        }
                    },
                    {
                        "exact_snippets": "has received ... any other immunosuppressive therapy within 4 weeks of the first dose of treatment",
                        "criterion": "immunosuppressive therapy (other than corticosteroids)",
                        "requirement": {
                            "requirement_type": "receipt",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "has received ... any other immunosuppressive therapy within 4 weeks of the first dose of treatment",
                        "criterion": "immunosuppressive therapy (other than corticosteroids)",
                        "requirement": {
                            "requirement_type": "time_window",
                            "expected_value": {
                                "operator": "<=",
                                "value": 4,
                                "unit": "weeks"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Diagnosis of immunodeficiency",
                        "criterion": "immunodeficiency",
                        "requirement": {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "has received more than replacement doses of corticosteroids ... within 4 weeks of the first dose of treatment",
                                "criterion": "corticosteroid therapy",
                                "requirement": {
                                    "requirement_type": "dose",
                                    "expected_value": {
                                        "operator": ">",
                                        "value": 1,
                                        "unit": "replacement dose"
                                    }
                                }
                            },
                            {
                                "exact_snippets": "has received more than replacement doses of corticosteroids ... within 4 weeks of the first dose of treatment",
                                "criterion": "corticosteroid therapy",
                                "requirement": {
                                    "requirement_type": "time_window",
                                    "expected_value": {
                                        "operator": "<=",
                                        "value": 4,
                                        "unit": "weeks"
                                    }
                                }
                            }
                        ]
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "has received ... any other immunosuppressive therapy within 4 weeks of the first dose of treatment",
                                "criterion": "immunosuppressive therapy (other than corticosteroids)",
                                "requirement": {
                                    "requirement_type": "receipt",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "has received ... any other immunosuppressive therapy within 4 weeks of the first dose of treatment",
                                "criterion": "immunosuppressive therapy (other than corticosteroids)",
                                "requirement": {
                                    "requirement_type": "time_window",
                                    "expected_value": {
                                        "operator": "<=",
                                        "value": 4,
                                        "unit": "weeks"
                                    }
                                }
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Known history of Human Immunodeficiency Virus (HIV) (HIV 1/2 antibodies), active Hepatitis B (e.g., HBsAg reactive) or Hepatitis C (e.g., HCV RNA [qualitative] is detected).",
                "criterions": [
                    {
                        "exact_snippets": "Known history of Human Immunodeficiency Virus (HIV) (HIV 1/2 antibodies)",
                        "criterion": "Human Immunodeficiency Virus (HIV) infection",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "active Hepatitis B (e.g., HBsAg reactive)",
                        "criterion": "Hepatitis B infection",
                        "requirement": {
                            "requirement_type": "activity",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Hepatitis C (e.g., HCV RNA [qualitative] is detected)",
                        "criterion": "Hepatitis C infection",
                        "requirement": {
                            "requirement_type": "activity",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Known history of Human Immunodeficiency Virus (HIV) (HIV 1/2 antibodies)",
                        "criterion": "Human Immunodeficiency Virus (HIV) infection",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "active Hepatitis B (e.g., HBsAg reactive)",
                        "criterion": "Hepatitis B infection",
                        "requirement": {
                            "requirement_type": "activity",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Hepatitis C (e.g., HCV RNA [qualitative] is detected)",
                        "criterion": "Hepatitis C infection",
                        "requirement": {
                            "requirement_type": "activity",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* History or current evidence of any condition, therapy, or laboratory abnormality that might confound the results of the trial, interfere with the subject's participation for the full duration of the trial, such that trial participation is not in the best interest of the subject, including but not limited to uncontrolled hypertension or clinically significant cardiovascular disease, myocardial infarction within the previous 3 months, active infection or pneumonitis or other pulmonary disease requiring systemic therapy, clinically significant gastritis or peptic ulcer disease (that would preclude the use of indomethacin), stroke of other symptoms of cerebral vascular insufficient within the last 3 months, autoimmune disease that has required systemic treatment within the past 2 years (other than hormone replacement doses), or uncontrolled psychiatric or substance abuse disorders.",
                "criterions": [
                    {
                        "exact_snippets": "uncontrolled hypertension",
                        "criterion": "hypertension",
                        "requirement": {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        }
                    },
                    {
                        "exact_snippets": "clinically significant cardiovascular disease",
                        "criterion": "cardiovascular disease",
                        "requirement": {
                            "requirement_type": "clinical significance",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "myocardial infarction within the previous 3 months",
                        "criterion": "myocardial infarction",
                        "requirement": {
                            "requirement_type": "time since event",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "months"
                            }
                        }
                    },
                    {
                        "exact_snippets": "active infection",
                        "criterion": "infection",
                        "requirement": {
                            "requirement_type": "activity",
                            "expected_value": "active"
                        }
                    },
                    {
                        "exact_snippets": "pneumonitis or other pulmonary disease requiring systemic therapy",
                        "criterion": "pulmonary disease",
                        "requirement": {
                            "requirement_type": "requires systemic therapy",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "clinically significant gastritis or peptic ulcer disease (that would preclude the use of indomethacin)",
                        "criterion": "gastritis or peptic ulcer disease",
                        "requirement": {
                            "requirement_type": "clinical significance",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "clinically significant gastritis or peptic ulcer disease (that would preclude the use of indomethacin)",
                        "criterion": "gastritis or peptic ulcer disease",
                        "requirement": {
                            "requirement_type": "precludes indomethacin use",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "stroke of other symptoms of cerebral vascular insufficient within the last 3 months",
                        "criterion": "stroke or cerebral vascular insufficiency symptoms",
                        "requirement": {
                            "requirement_type": "time since event",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "months"
                            }
                        }
                    },
                    {
                        "exact_snippets": "autoimmune disease that has required systemic treatment within the past 2 years (other than hormone replacement doses)",
                        "criterion": "autoimmune disease",
                        "requirement": {
                            "requirement_type": "systemic treatment required",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "autoimmune disease that has required systemic treatment within the past 2 years (other than hormone replacement doses)",
                        "criterion": "autoimmune disease",
                        "requirement": {
                            "requirement_type": "time since treatment",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "years"
                            }
                        }
                    },
                    {
                        "exact_snippets": "autoimmune disease that has required systemic treatment within the past 2 years (other than hormone replacement doses)",
                        "criterion": "autoimmune disease",
                        "requirement": {
                            "requirement_type": "treatment type exclusion",
                            "expected_value": "hormone replacement doses"
                        }
                    },
                    {
                        "exact_snippets": "uncontrolled psychiatric or substance abuse disorders",
                        "criterion": "psychiatric or substance abuse disorders",
                        "requirement": {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "uncontrolled hypertension",
                        "criterion": "hypertension",
                        "requirement": {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        }
                    },
                    {
                        "exact_snippets": "clinically significant cardiovascular disease",
                        "criterion": "cardiovascular disease",
                        "requirement": {
                            "requirement_type": "clinical significance",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "myocardial infarction within the previous 3 months",
                        "criterion": "myocardial infarction",
                        "requirement": {
                            "requirement_type": "time since event",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "months"
                            }
                        }
                    },
                    {
                        "exact_snippets": "active infection",
                        "criterion": "infection",
                        "requirement": {
                            "requirement_type": "activity",
                            "expected_value": "active"
                        }
                    },
                    {
                        "exact_snippets": "pneumonitis or other pulmonary disease requiring systemic therapy",
                        "criterion": "pulmonary disease",
                        "requirement": {
                            "requirement_type": "requires systemic therapy",
                            "expected_value": true
                        }
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "clinically significant gastritis or peptic ulcer disease (that would preclude the use of indomethacin)",
                                "criterion": "gastritis or peptic ulcer disease",
                                "requirement": {
                                    "requirement_type": "clinical significance",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "clinically significant gastritis or peptic ulcer disease (that would preclude the use of indomethacin)",
                                "criterion": "gastritis or peptic ulcer disease",
                                "requirement": {
                                    "requirement_type": "precludes indomethacin use",
                                    "expected_value": true
                                }
                            }
                        ]
                    },
                    {
                        "exact_snippets": "stroke of other symptoms of cerebral vascular insufficient within the last 3 months",
                        "criterion": "stroke or cerebral vascular insufficiency symptoms",
                        "requirement": {
                            "requirement_type": "time since event",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "months"
                            }
                        }
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "autoimmune disease that has required systemic treatment within the past 2 years (other than hormone replacement doses)",
                                "criterion": "autoimmune disease",
                                "requirement": {
                                    "requirement_type": "systemic treatment required",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "autoimmune disease that has required systemic treatment within the past 2 years (other than hormone replacement doses)",
                                "criterion": "autoimmune disease",
                                "requirement": {
                                    "requirement_type": "time since treatment",
                                    "expected_value": {
                                        "operator": "<=",
                                        "value": 2,
                                        "unit": "years"
                                    }
                                }
                            },
                            {
                                "exact_snippets": "autoimmune disease that has required systemic treatment within the past 2 years (other than hormone replacement doses)",
                                "criterion": "autoimmune disease",
                                "requirement": {
                                    "requirement_type": "treatment type exclusion",
                                    "expected_value": "hormone replacement doses"
                                }
                            }
                        ]
                    },
                    {
                        "exact_snippets": "uncontrolled psychiatric or substance abuse disorders",
                        "criterion": "psychiatric or substance abuse disorders",
                        "requirement": {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Received an investigational agent within 4 weeks of the first dose of treatment.",
                "criterions": [
                    {
                        "exact_snippets": "Received an investigational agent within 4 weeks of the first dose of treatment.",
                        "criterion": "receipt of investigational agent",
                        "requirement": {
                            "requirement_type": "time since last receipt",
                            "expected_value": {
                                "operator": "<=",
                                "value": 4,
                                "unit": "weeks"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Received an investigational agent within 4 weeks of the first dose of treatment.",
                        "criterion": "receipt of investigational agent",
                        "requirement": {
                            "requirement_type": "time since last receipt",
                            "expected_value": {
                                "operator": "<=",
                                "value": 4,
                                "unit": "weeks"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Chronic anticoagulation, not including aspirin, but including heparins, warfarin, oral anticoagulants or other platelet function inhibitors, that cannot, in the documented opinion of the investigator, safely be interrupted from at least 2 days prior to the initiation of the study regimen until after surgical resection of the tumor.",
                "criterions": [
                    {
                        "exact_snippets": "Chronic anticoagulation, not including aspirin, but including heparins, warfarin, oral anticoagulants or other platelet function inhibitors, that cannot, in the documented opinion of the investigator, safely be interrupted from at least 2 days prior to the initiation of the study regimen until after surgical resection of the tumor.",
                        "criterion": "chronic anticoagulation (excluding aspirin, including heparins, warfarin, oral anticoagulants, or other platelet function inhibitors)",
                        "requirement": {
                            "requirement_type": "interruptibility",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "Chronic anticoagulation, not including aspirin, but including heparins, warfarin, oral anticoagulants or other platelet function inhibitors, that cannot, in the documented opinion of the investigator, safely be interrupted from at least 2 days prior to the initiation of the study regimen until after surgical resection of the tumor.",
                        "criterion": "chronic anticoagulation (excluding aspirin, including heparins, warfarin, oral anticoagulants, or other platelet function inhibitors)",
                        "requirement": {
                            "requirement_type": "interruption_time_window",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 2,
                                        "unit": "days"
                                    }
                                ]
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Chronic anticoagulation, not including aspirin, but including heparins, warfarin, oral anticoagulants or other platelet function inhibitors, that cannot, in the documented opinion of the investigator, safely be interrupted from at least 2 days prior to the initiation of the study regimen until after surgical resection of the tumor.",
                        "criterion": "chronic anticoagulation (excluding aspirin, including heparins, warfarin, oral anticoagulants, or other platelet function inhibitors)",
                        "requirement": {
                            "requirement_type": "interruptibility",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "Chronic anticoagulation, not including aspirin, but including heparins, warfarin, oral anticoagulants or other platelet function inhibitors, that cannot, in the documented opinion of the investigator, safely be interrupted from at least 2 days prior to the initiation of the study regimen until after surgical resection of the tumor.",
                        "criterion": "chronic anticoagulation (excluding aspirin, including heparins, warfarin, oral anticoagulants, or other platelet function inhibitors)",
                        "requirement": {
                            "requirement_type": "interruption_time_window",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 2,
                                        "unit": "days"
                                    }
                                ]
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Pregnancy or lactation.",
                "criterions": [
                    {
                        "exact_snippets": "Pregnancy",
                        "criterion": "pregnancy",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "lactation",
                        "criterion": "lactation",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Pregnancy",
                        "criterion": "pregnancy",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "lactation",
                        "criterion": "lactation",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Prior neoadjuvant systemic therapy is planned",
                "criterions": [
                    {
                        "exact_snippets": "Prior neoadjuvant systemic therapy is planned",
                        "criterion": "neoadjuvant systemic therapy",
                        "requirement": {
                            "requirement_type": "planned",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "not_criteria": {
                    "exact_snippets": "Prior neoadjuvant systemic therapy is planned",
                    "criterion": "neoadjuvant systemic therapy",
                    "requirement": {
                        "requirement_type": "planned",
                        "expected_value": true
                    }
                }
            }
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [
        {
            "identified_line": {
                "line": "* To undergo surgical resection with curative intent by partial mastectomy (lumpectomy) or mastectomy or",
                "criterions": [
                    {
                        "exact_snippets": "To undergo surgical resection with curative intent by partial mastectomy (lumpectomy) or mastectomy",
                        "criterion": "surgical resection with curative intent",
                        "requirement": {
                            "requirement_type": "procedure type",
                            "expected_value": [
                                "partial mastectomy (lumpectomy)",
                                "mastectomy"
                            ]
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "* Female or male â‰¥18 years of age on day of signing informed consent.",
                "criterions": [
                    {
                        "exact_snippets": "Female or male",
                        "criterion": "sex",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": [
                                "female",
                                "male"
                            ]
                        }
                    },
                    {
                        "exact_snippets": "â‰¥18 years of age",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "age",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    },
                    {
                        "exact_snippets": "on day of signing informed consent",
                        "criterion": "informed consent signed",
                        "requirement": {
                            "requirement_type": "signed",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "* Tumor >5 mm in maximum diameter by ultrasound or mammography. (Subjects with smaller tumors may be included at the discretion of the Principal Investigator.)",
                "criterions": [
                    {
                        "exact_snippets": "Tumor >5 mm in maximum diameter by ultrasound or mammography",
                        "criterion": "tumor size",
                        "requirement": {
                            "requirement_type": "maximum diameter",
                            "expected_value": {
                                "operator": ">",
                                "value": 5,
                                "unit": "mm"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Tumor >5 mm in maximum diameter by ultrasound or mammography",
                                "criterion": "tumor size",
                                "requirement": {
                                    "requirement_type": "maximum diameter",
                                    "expected_value": {
                                        "operator": ">",
                                        "value": 5,
                                        "unit": "mm"
                                    }
                                }
                            }
                        ]
                    },
                    {
                        "exact_snippets": "Subjects with smaller tumors may be included at the discretion of the Principal Investigator",
                        "criterion": "tumor size",
                        "requirement": {
                            "requirement_type": "Principal Investigator discretion for smaller tumors",
                            "expected_value": true
                        }
                    }
                ]
            }
        }
    ],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}